"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
Amid widespread concern over Thrombosis with Thrombocytopenia Syndrome - a rare side-effect of the Covishield COVID-19 vaccine - the Serum Institute - which made the drug developed by British pharma giant AstraZeneca - has said that all its product packaging had "disclosed all rare to very rare side-effects", including TTS. The vaccine's safety "remains paramount", the company said Wednesday, pointing out the drug, as Covishield, had been "instrumental in saving millions of lives worldwide".
Through RSS Feeds 
Amid widespread concern over Thrombosis with Thrombocytopenia Syndrome - a rare side-effect of the Covishield COVID-19 vaccine - the Serum Institute - which made the drug developed by British pharma giant AstraZeneca - has said that all its product packaging had "disclosed all rare to very rare side-effects", including TTS. The vaccine's safety "remains paramount", the company said Wednesday, pointing out the drug, as Covishield, had been "instrumental in saving millions of lives worldwide".
